317 related articles for article (PubMed ID: 3037870)
1. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
Eke PI; Rotimi VO
Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
[TBL] [Abstract][Full Text] [Related]
2. [Susceptibility to antimicrobial agents of 2,060 strains of different bacteria isolated in infectious processes in children].
Filloy L; Borjas E; Sierra A
Bol Med Hosp Infant Mex; 1981; 38(1):13-21. PubMed ID: 7025858
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
Dolna I; Ruczkowska J; Chomontowicz M
Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147
[TBL] [Abstract][Full Text] [Related]
4. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
Eley A; Ibrahim M; Kurdi SE; Conlon JM
Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
[TBL] [Abstract][Full Text] [Related]
5. Effects of saliva and alpha-amylase on antibiotic sensitivity of bacteria.
Eke PI; Rotimi VO; Odugbemi TO; Dosunmu-Ogunbi OO
Afr J Med Med Sci; 1984; 13(1-2):15-20. PubMed ID: 6087634
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
Shah PM; Zwischenbrugger H; Stille W
MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
[TBL] [Abstract][Full Text] [Related]
7. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
Greco F; Rossi A; De Palma L; Spagnolo N
Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
[TBL] [Abstract][Full Text] [Related]
8. [Increased antibacterial activity of antibiotics with etonium in vitro].
Petrunyk IO
Mikrobiol Z; 2000; 62(4):43-6. PubMed ID: 11421003
[TBL] [Abstract][Full Text] [Related]
9. [In vitro study of the effect of sodium chloride on the activity of 5 families of antibiotics on gram-negative bacilli].
Denis F; Geslin MM
Arch Roum Pathol Exp Microbiol; 1974 Mar; 33(1):33-9. PubMed ID: 4208056
[No Abstract] [Full Text] [Related]
10. Nationwide survey of antibiotic resistance by means of a computer. An introduction into the analysis of multiple antibiotic resistance.
Grunt J; Krcméry V
Zentralbl Bakteriol Orig A; 1975 Aug; 232(4):521-33. PubMed ID: 812292
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
Lee ML; Tan NH; Fung SY; Sekaran SD
Comp Biochem Physiol C Toxicol Pharmacol; 2011 Mar; 153(2):237-42. PubMed ID: 21059402
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
14. Nation-wide survey of antibiotic resistance by means of a computer. Analysis of 200.000 strains of problem bacteria isolated in 1973.
Krcméry V; Grunt J; Rosival L; Vymola F
Zentralbl Bakteriol Orig A; 1975; 231(1-3):250-8. PubMed ID: 808050
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
18. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
19. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
De Rosa F; Tassi C; Stagni GR
Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
[No Abstract] [Full Text] [Related]
20. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
